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Gene UL9 of herpes simplex virus type 1 encodes an 851-amino-acid protein which is essential for viral DNA synthesis and
functions as a sequence-specific origin-binding protein and DNA helicase. We generated monoclonal antibodies against
purified UL9 protein and identified one such antibody (MAb 13924) that can block the interaction of the UL9 C-terminal
DNA-binding domain (amino acids 534–851) with its recognition sequence. MAb 13924 interacted with immobilized peptides
containing residues 780–786 of UL9. Although the corresponding region of the homologous protein encoded by varicella-
zoster virus differs at only a single position it was not recognized by MAb 13924. Site-directed mutagenesis experiments
confirmed that residues within this region contribute to the epitope recognized by MAb 13924 and may be involved in
sequence-specific DNA binding. In addition, all eight lysine residues within the DNA-binding domain were separately changed
to alanine and the DNA-binding properties of the mutated proteins were examined. The results showed that lysine residues
that are located close to the peptide recognized by MAb 13924 or lie within the region of the DNA-binding domain most highly
conserved among homologous alphaherpesvirus proteins play a role in sequence-specific DNA binding. Moreover, alteration
of a lysine residue 18 amino acids from the recognized peptide prevented the interaction of MAb 13924 with the UL9
C-terminal DNA-binding domain. Three helical segments are predicted to occur within the region containing mutations that
affect sequence-specific binding and interaction with MAb 13924. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus type 1 (HSV-1), like other mem-
bers of the family Herpesviridae, has a large double-
stranded linear DNA genome. Seven virus-coded pro-
teins perform direct and essential roles in the replication
of the genome and three cis-acting elements which func-
tion as origins of DNA synthesis have been identified
(reviewed by Challberg, 1991). By analogy with other
replicons, a key event in the initiation of HSV-1 DNA
synthesis is believed to be the sequence-specific recog-
nition of the replication origins by the viral origin-binding
protein UL9 (Olivo et al., 1988).
UL9 is an 851-amino-acid protein (McGeoch et al.,
1988) that exists as a dimer in solution (Bruckner et al.,
1991; Fierer and Challberg, 1992) and comprises two
essential functional domains (Martinez et al., 1992; Stow
et al., 1993). Residues 1–534 specify DNA helicase and
DNA-dependent ATPase activities (Abbotts and Stow,
1995), while amino acids 535–851 are sufficient for se-
quence-specific DNA binding to the origins (Weir et al.,
1989) and contain a region important for specific inter-
action with the viral single-stranded DNA-binding pro-
tein, UL29 or ICP8 (Boehmer et al., 1994). Each of the viral
origins contains two high-affinity UL9 binding sites that
are necessary for efficient function (Weir and Stow, 1990;
Hernandez et al., 1991; Martin et al., 1991). These are
located on the opposite arms of a DNA palindrome,
separated by an approximately 30-bp AT-rich region, and
a consensus recognition sequence YGYTCGCACT
(where Y is a pyrimidine) has been determined. In the
case of oris, two copies of which lie in the inverted
repeats flanking the Us region, the two binding sites
differ approximately fivefold in their affinity for UL9 (Elias
and Lehman, 1988; Olivo et al., 1988; Koff and Tegtmeyer,
1988). Site I, the higher affinity site, has the sequence
CGTTCGCACT, and site II, TGCTCGCACT. In contrast,
both UL9 binding sites within oriL, located near the cen-
ter of the UL region, have the site I sequence. The
C-terminal DNA-binding domain, when expressed alone,
is monomeric in solution (Elias et al., 1992), but contro-
versy remains as to whether one (Martin et al., 1994;
Gustafsson et al., 1995) or two (Stabell and Olivo, 1993;
Fierer and Challberg, 1995) molecules bind to a single
copy of the UL9 recognition sequence.
The above structural arrangement of the replication
origin and the presence of a UL9 homolog are features
that are largely specific to the alphaherpesvirus subfam-
ily. Two notable exceptions are human herpesviruses 6
and 7 (HHV-6 and HHV-7) which, although they are be-
taherpesviruses, also contain homologues of UL9 and
similarly structured replication origins (Inoue and Pellett,
1995; van Loon et al., 1997). The sequences of functional
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or putative replication origins and the cognate origin
binding proteins (OBPs) are available for six alphaher-
pesviruses including HSV-1. DNA-binding assays and
sequence comparisons indicate that the UL9 homologs
of varicella-zoster virus (VZV), Marek’s disease virus
(MDV), equine herpesvirus 1 (EHV-1), bovine herpesvirus
1 (BHV-1), and pseudorabies virus (PRV) all recognize
sequences identical, or very similar, to the HSV-1 UL9-
binding site (Schwyzer et al., 1994, and references
therein) suggesting that residues that are particularly
well conserved among these proteins may be important
for sequence-specific DNA binding. Although a detailed
comparison of all six proteins has not been reported, a
major region of conservation between the OBPs of HSV-1
and VZV corresponding to amino acids 730–810 of UL9
and exhibiting over 55% sequence identity has been
described (Stow et al., 1990; Chen and Olivo, 1994; Mar-
tin et al., 1994). This region additionally represents the
one area of significant sequence similarity that the ori-
gin-binding domain of the HHV-6 OBP shares with its
alphaherpesvirus homologs (Inoue and Pellett, 1995). In
Southwestern blots, amino acids 689–851 of UL9 and the
region of HHV-6 OBP corresponding to UL9 amino acids
712–818 are sufficient for sequence-specific binding to
their respective recognition sequences indicating that
the conserved region may play a direct role in sequence-
specific binding (Inoue and Pellett, 1995). However, since
these subdomains of the HSV-1 and HHV-6 OBPs fail to
bind to their recognition sites in solution, it is clear that
additional sequences must contribute to the formation of
a functional DNA-binding domain.
In an attempt to identify directly regions of the HSV-1
UL9 DNA-binding domain involved in sequence-specific
recognition, several series of mutagenesis experiments
have been performed. These have examined the ability
of deletion or insertion mutants to interact with the bind-
ing site sequence in solution (e.g., in electrophoretic
mobility shift assays). The results show that the N- and
C-terminal boundaries of the DNA-binding domain are
most probably located between residues 565–596 and
802–818 of UL9, respectively, and that a variety of in-
frame insertion mutations of 2–6 amino acids across the
region between residues 581–804 disrupt binding (Deb
and Deb, 1991; Martinez et al., 1992; Arbuckle and Stow,
1993; Martin et al., 1994). Within the major conserved
sequence block, insertions at two positions abolished
binding while those at three other sites had inhibitory
effects (Deb and Deb, 1991; Arbuckle and Stow, 1993;
Martin et al., 1994). Insertions of amino acids may, how-
ever, have quite long-range effects on protein folding,
and to date there have been no reports on the conse-
quences of specific amino acid substitutions. The latter
mutations might be expected to cause less overall dis-
ruption to the folding of the protein and have the potential
to identify individual amino acids that function in se-
quence-specific recognition.
The experiments described in this paper combine two
approaches in order to identify residues within the DNA-
binding domain that contribute to sequence-specific
binding. First, a monoclonal antibody which blocks se-
quence-specific binding was characterized and shown to
interact with residues within the major conserved region.
Second, the effect on DNA binding of systematically
substituting each of the eight lysine residues, six of
which lie within the conserved region, was investigated.
MATERIALS AND METHODS
Protein expression
The BamHI fragment encoding the C-terminal region
of UL9 was excised from a pUC8 recombinant containing
the full-length gene (Weir et al., 1989) and inserted into
the BamHI site of the expression vector pET23b (Nova-
gen). The resulting construct (pET9CT) encodes a 329-
amino-acid fusion protein (9CT, predicted MW 36029)
comprising the N-terminal residues MASMTGGQQMGR,
specified by the vector, linked to residues 535–851 of
UL9 expressed under the control of a phage T7 promoter.
Escherichia coli strain BL21(DE3)pLysS was used
throughout for expression of wild-type (wt) and mutated
forms of the 9CT protein. Cultures were grown at 37°C to
an OD of 0.4 in LB containing 50 mg/ml ampicillin and 15
mg/ml chloramphenicol. IPTG induction was omitted
since although increased yields of 9CT were obtained a
substantial proportion became insoluble. The cells from
1.5 ml of culture were pelleted by centrifugation, resus-
pended in 0.4 ml buffer C (20 mM HEPES–NaOH, pH 7.9,
600 mM NaCl, 25% glycerol, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 0.5 mM PMSF), and sonicated on ice.
The sonicates were centrifuged at 11,600 g for 10 min
and the supernatant fractions were used as extracts.
Approximately 50% of the total wt and mutant UL9CT
proteins (with the exception of K556A; see Results) was
recovered in the supernatants. A fragment specifying the
C-terminal domain (amino acids 514–835; Stow et al.,
1990) of the VZV origin-binding protein (gene 51 product)
was similarly cloned and expressed (51CT protein).
Site-directed mutagenesis
Specific mutations were introduced into plasmid
pET9CT by the method of Kunkel (1985). E. coli strain
CJ236 (dut2 ung2; New England Biolabs) containing
pET9CT was grown and infected with helper phage R408
in the presence of 100 mg/ml uridine. Single-stranded
phage DNA was prepared and annealed to mutagenic
oligonucleotides. The oligonucleotides were designed
so as to alter the desired amino acid and also incorpo-
rated silent base changes which facilitated the identifi-
cation of mutated plasmids by causing a gain or loss of
a restriction endonuclease site (Table 1). Second-strand
synthesis was performed with T7 DNA polymerase (New
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England Biolabs) in the presence of T4 DNA ligase. The
products were transformed into E. coli strain DH5. Col-
onies carrying the mutated plasmid were identified by
restriction endonuclease digestion, and the identities of
the plasmids were confirmed by DNA sequencing. Fi-
nally the mutated plasmids were transferred into E. coli
strain BL21(DE3)pLysS for expression of the mutant pro-
teins.
Antibodies
Full-length UL9 protein was purified from Spodoptera
frugiperda cells infected with the recombinant baculovi-
rus AcUL9 (Stow, 1992; Abbotts and Stow, 1995) and used
to immunize female BALB/c mice. Hybridoma lines se-
creting monoclonal antibodies (MAbs) were generated
essentially as described previously (McLean et al., 1994),
and antibodies able to react with UL9 in an ELISA assay
were characterized in further detail. MAb 0811 against
the UL8 protein has been described previously (McLean
et al., 1994) and a rabbit antiserum raised against a
peptide comprising the C-terminal 10 amino acids of UL9
(Olivo et al., 1989; 9CT antipeptide serum) was a kind gift
of Dr. M. D. Challberg. MAbs were used either as ascitic
fluids or as tissue culture supernatants with essentially
identical results.
Gel mobility shift assay
Gel mobility shift assays were performed as previously
described using 32P-labeled double-stranded oligonucle-
otides containing either the binding site I or the binding
site II sequences (Arbuckle and Stow, 1993). Binding
reactions were set up by adding 6 ml extract (containing
approximately 3 mg protein) in buffer C to 24 ml 10 mM
Tris–HCl, pH 8.0, 10% glycerol, 100 mg/ml BSA, 5 mM
DTT, 1 mg sonicated calf thymus DNA, and 1 ng 32P-
labeled oligonucleotide. Following incubation for 20 min,
6-ml loading dyes were added and the samples were
subjected to electrophoresis through an 8% nondenatur-
ing polyacrylamide gel. To examine the effects of MAbs
on complex formation, 1 ml ascitic fluid was added to the
binding reaction immediately prior to the extract. Unless
TABLE 1
Mutations Introduced into the Region Encoding the UL9 C-Terminal DNA-Binding Domaina
Mutant Wild type sequence Mutant sequence Enzyme site
ooo
K556A GTC GAA AAA TAC GTC GAA GCT TAC HindIII
V E K Y V E A Y
ooo o
K707A GTC AAG CGC GTC GTC GCT CGA GTC XhoI
V K R V V A R V
oo
K733A CTG TTC AAG ATA CTG TTC GCG ATA NruI
L F K I L F A I
ooo
K746A GCC AAA AGC ACG GCC GCT AGC ACG NheI
A K S T A K A T
o ooo
K758A CGC GTT AAA AAC CGC GTC GCG AAC NruI
R V K N R V A N
o ooo
K762A CTC ACC AAA CAG CTC ACT GCG CAG FspI
L T K Q L T A Q
o o
H782Y CAC AGG CAG CTG TAC AGG CAA CTG PvuII
H R Q L Y R Q L
oo oo
RQ783AA CAC AGG CAG CTG CAC GCG GCG CTG PvuII
H R Q L H A A L
ooo o
K793A CAC AAG CGG GAG CAC GCT CGA GAG XhoI
H K R E H A R E
oo o
K802A AAG CTA CGC GTG GCG CTC CGC GTG MluI
K L R V A L R V
a The sequences of the corresponding regions of the wild-type and mutant 9CT genes and proteins are presented. Restriction endonuclease sites
introduced into or removed from the wt sequence are underlined and o indicates nucleotide changes. The positions of the mutations are illustrated
diagrammatically in Fig. 7.
185DNA-BINDING DOMAIN OF HSV-1 UL9
otherwise stated incubations and electrophoresis were
performed at room temperature (approximately 22°C).
Western blots
Samples of extract containing approximately 1.5 mg
protein in denaturing buffer were resolved on 10% SDS–
PAGE gels, electroblotted onto nitrocellulose mem-
branes, and blocked at 22°C as described by Arbuckle
and Stow (1993). The membranes were incubated for 90
min at 22°C in 4 ml TTBS (10 mM Tris–HCl, pH 8.0, 150
mM NaCl, 0.05% Tween 20) containing either 1 ml MAb
13924 ascitic fluid or 16 ml 9CT antipeptide serum and
washed with TTBS. Bound antibody was detected using
the Promega Protoblot system in conjunction with an
anti-mouse or anti-rabbit IgG (as appropriate) alkaline
phosphatase-conjugated secondary antibody according
to the manufacturer’s instructions.
RESULTS
Monoclonal antibodies against the UL9 protein
Further screening of 11 Mabs that reacted with UL9 in
an ELISA assay identified 4 which recognized UL9 on
Western blots and in immunoprecipitation and immuno-
fluorescence assays. The approximate positions of the
epitopes recognized by these 4 MAbs were initially
mapped using UL9 deletion mutants expressed in E. coli
or by baculovirus recombinants (data not shown). The
locations were refined by subsequent screening for re-
activity against series of overlapping peptides by the
SPOTs technique (Genosys, Cambridge). Two MAbs
(13938 and 13979) recognized an epitope within the N-
terminal 10 amino acids. MAbs 13762 and 13924 reacted
with amino acids 107–112 and 780–786 of UL9, respec-
tively.
Binding of UL9 to HSV-1 origin binding site I is
blocked by MAb 13924
Since MAb 13924 recognized an epitope within the
C-terminal DNA binding domain of UL9, its ability to
block sequence-specific binding was examined. An ex-
tract from E. coli cells expressing 9CT protein was incu-
bated with a 32P-labeled probe containing origin binding
site I (OBS I) either in the presence or in the absence of
MAb and protein–DNA complexes resolved on a nonde-
naturing polyacrylamide gel. Figure 1a shows that, as
expected, a retarded complex was obtained in the ab-
sence of antibody. The presence MAb 13762 or MAb
0811 (against UL8) in the binding reaction did not affect
complex formation. In contrast, binding was almost com-
pletely abolished in the presence of MAb 13924. A sim-
ilar experiment demonstrated that MAb 13924 also inhib-
ited complex formation by full-length UL9 (Fig. 1b),
although, as previously noted (e.g., Weir et al., 1989), the
intact protein did not yield as discrete a pattern of re-
tarded complexes.
The effect of preincubating an extract containing 9CT
protein with either the oligonucleotide probe or the
monoclonal antibody is shown in Fig. 1c. Lanes 1–3, in
which extract and probe were preincubated for 20 min
followed by addition of the indicated antibody for an
additional 20 min prior to electrophoresis, reveal a small
reduction in the amount of complex formed in the pres-
ence of MAb 13924 and the absence of a slower migrat-
ing form which might result from binding of antibody
molecules to protein–DNA complexes (lane 3). In con-
trast, preincubation with MAb 13924 for 20 min prior to
addition of labeled probe for an additional 20 min pre-
FIG. 1. Inhibition of UL9 and UL9CT binding to OBS I. (a) Labeled
probe was incubated with (lanes 1–4) or without (lane 5) extract con-
taining 9CT protein in the additional presence of 1 ml of the following
ascitic fluids: MAb 13924 (lane 2), MAb 13762 (lane 3), and MAb 0811
(lane 4). (b) Labeled probe was incubated with purified UL9 protein in
the absence (lane 1) or presence (lane 2) of 1 ml MAb 13924 ascitic
fluid. (c) Extract containing 9CT protein was preincubated with labeled
probe (lanes 1–3) or the indicated MAb (lanes 4–6) for 20 min prior to
addition of either the indicated MAb (lanes 1–3) or labeled probe (lanes
4–6) for an additional 20 min. Protein–DNA complexes were resolved
by electrophoresis through nondenaturing 8% polyacrylamide gels. The
positions of the free probe and retarded complexes are shown.
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vented the formation of a retarded complex (lane 6).
These data suggest that the epitope recognized by MAb
13924 may lie at or close to the UL9 sequence-specific
DNA-binding site, such that binding of antibody prevents
sequence-specific recognition of binding site I and vice
versa. The reduced yield of complex in lane 3 compared
to lanes 1 and 2 probably reflects dissociation of protein–
DNA complexes and binding of MAb 13924 to free 9CT
molecules preventing further interaction with DNA during
the second phase of the reaction. This is analogous to
the effect observed upon addition of an excess of unla-
beled competitor DNA after initial preincubation of 9CT
protein with labeled probe (Elias et al., 1992).
The VZV 51 protein is not recognized by MAb 13924
Comparison of the sequences of HSV-1 UL9 and the
VZV gene 51 protein revealed that the sequence recog-
nized by MAb 13924 (RTHRQLY) is present at the corre-
sponding position in the VZV protein (amino acids 762–
768) with only a single amino acid change (RTYRQLY).
The reactivity of MAb 13924 with the C-terminal domain
of the VZV protein, 51CT, was therefore examined in a
Western blot and its ability to block the binding of the
protein to DNA was tested. As a control, an antibody
against the C-terminus of UL9 (9CT antipeptide serum),
which had previously been demonstrated to also recog-
nize VZV 51 protein (Chen et al., 1995), was included.
Figure 2a shows a Western blot analysis of the ex-
pressed proteins. With the 9CT antipeptide serum some
proteins were detected nonspecifically in extracts of
cells transformed with the parental plasmid vector (lane
V). In agreement with previous results (Chen et al., 1995)
this antiserum additionally detected both the 9CT and the
51CT proteins (lanes HSV-1 9CT and VZV 51CT, respec-
tively). In contrast, MAb 13924 detected the HSV-1 but not
the VZV product.
Both proteins formed complexes with an OBS I probe
which could be detected in a gel mobility shift assay (Fig.
2b, lanes 1 and 4). In addition the 9CT antipeptide serum
was able to bind to complexes containing the 9CT and
51CT proteins generating supershifted complexes of fur-
ther reduced mobility (lanes 3 and 6). In agreement with
its failure to recognize 51CT in a Western blot, MAb
13924 had no effect on complex formation between 51CT
and OBS I (lane 5). These results suggest that the single
amino acid difference between the HSV-1 peptide and
the corresponding sequence in VZV 51 may be sufficient
to prevent recognition by MAb 13924. In addition, they
provide important evidence that the blocking of the in-
teraction between 9CT and OBS I is a highly specific
event dependent upon recognition of the protein by the
antibody.
Mutagenesis of the MAb 13924 epitope
To confirm the importance of the histidine residue
within the peptide recognized by MAb 13924 (RTHRQLY),
a specifically mutated form of 9CT (H782Y) was ex-
pressed containing the corresponding VZV sequence
(RTYRQLY). A second mutated protein, RQ783AA, in
which the sequence was changed to RTHAALY was
similarly expressed. Both mutant proteins reacted with
9CT antipeptide serum on a Western blot, whereas MAb
13924 detected RQ783AA but not H782Y (Fig. 3a). The
H782Y mutant retained full OBS I binding ability which
was not inhibited in the presence of MAb 13924 (Fig. 3b).
A DNA complex was formed between RQ783AA and OBS
I but there was reproducibly considerable smearing in
the gel between the positions of the free probe and the
FIG. 2. MAb 13924 does not interact with VZV 51CT protein. (a) Western blot analysis. Extracts from cells expressing HSV-1 9CT or VZV 51CT or
transformed with the parental vector pET23b (V) were separated by PAGE and transferred to nitrocellulose membranes. Replicate membranes were
probed with MAb 13924 or 9CT antipeptide serum as indicated. (b) Electrophoretic mobility shift assay. Labeled OBS I probe was incubated without
extract (lane 7) or with extracts containing 9CT (lanes 1–3) or 51CT (lanes 4–6) proteins. MAb 13924 or 9CT antipeptide serum was added to the
binding reactions as indicated. Complexes were resolved as described in the legend to Fig. 1. Additional low-mobility, supershifted complexes can
be seen near the top of the gel (lanes 3 and 6).
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retarded complex. The probable explanation for this is an
increased tendency for the protein–DNA complex to dis-
sociate under gel electrophoresis conditions compared
to the complex formed with wt 9CT protein. Formation of
this complex was inhibited by MAb 13924. These results
confirm that H782 is an important component of the MAb
13924 epitope but indicate that the identity of residues
783 and 784 is not critical for antibody recognition of the
protein. Nevertheless, either R783 or Q784 (or both) may
have a role in DNA binding.
Mutagenesis of lysine residues within the UL9
C-terminal DNA binding domain
Eight lysine residues are present in the 9CT protein
corresponding to positions 556, 707, 733, 746, 758, 762,
793, and 802 of whole UL9. Seven of these cluster toward
the C-terminus near the peptide recognized by MAb
13924 in the SPOTS assay and within the region shown
to be capable of sequence-specific DNA binding in a
Southwestern blot (Inoue and Pellett, 1995). To investi-
gate whether any of these lysine residues might be
involved in sequence-specific DNA binding each was
individually changed to alanine and the mutated proteins
were expressed in E. coli. Extracts containing the mutant
and wt proteins were prepared and the relative amounts
of 9CT-related protein were compared following detec-
tion on a Western blot with 9CT antipeptide serum. With
the exception of K556A, each of the proteins was con-
sistently obtained in very similar amounts to the wt 9CT.
The relative yield of K556A was variable but generally
25–50% of wt (data not shown). Figure 4a shows a gel
mobility shift assay in which binding reactions and gel
electrophoresis were performed at 22°C. Mutants K707A
and K802A produced patterns essentially indistinguish-
able from 9CT and mutant H782Y (i.e., a discrete re-
tarded complex and little smearing in the region between
the complex and free probe). Mutants K733A, K746A,
K762A, and K793A all generated a retarded complex, but
like mutant RQ783AA a somewhat smeared pattern of
binding was observed. No retarded complex was de-
tected with K758A, and K556A exhibited reduced binding
compared to 9CT. These results indicate that lysine res-
idues at positions 733, 746, 758, 762, and 793 may have
a role in sequence-specific DNA binding.
The abilities of the mutant proteins to interact with
OBS I at 37°C were compared by performing both the
binding reactions and gel electrophoresis at the higher
temperature. Figure 4b shows that whereas wt 9CT pro-
tein bound with comparable efficiency at 37 and 22°C,
binding of the K556A protein was detectable only at
22°C. The remaining mutants exhibited similar behavior
at the two temperatures with respect to whether they
generated discrete or smeared patterns of binding. How-
ever, some reduction in complex formation was ob-
served with K793A.
When binding reactions and gel electrophoresis were
performed at 4°C (Fig. 4c), K556A formed a complex with
the OBS I probe with an efficiency similar to the wt
protein. Mutants that produced a smeared pattern at
room temperature and 37°C behaved similarly at 4°C,
e.g., K746A and K733A. A very weak interaction between
K758A and the probe was detected only at 4°C.
Binding of mutant proteins to HSV-1 OBS II
The ability of the mutant proteins to bind to an oligo-
nucleotide containing the OBS II sequence was also
examined. Figure 5 shows that, as with the OBS I probe,
K707A and H782Y were unimpaired in binding whilst
K758A failed to form a detectable complex. K802A exhib-
ited decreased binding and a weak interaction with K556A
was detected only on some occasions. Interestingly the
mutants that exhibited an altered smeared pattern with
FIG. 3. Analysis of mutants H782Y and RQ783AA. (a) Western blots performed on extracts from cells expressing 9CT, H782Y, and RQ783AA proteins.
Replicate membranes were probed with MAb 13924 or 9CT antipeptide serum as indicated. (b) Electrophoretic mobility shift assay. Labeled OBS I
probe was incubated with extracts containing the indicated proteins in the presence or absence of MAb 13924 and analyzed as described in the
legend to Fig. 1. Lanes V and P, incubation with extract from cells transformed with the parental vector and without extract, respectively.
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the OBS I probe (K733A, K746A, K762A, RQ783AA, K793A)
exhibited a greater impairment in their interaction with
the OBS II probe.
MAb 13924 does not recognize the K762A mutant
While comparing the yields of mutant proteins on a
Western blot we made the surprising observation that
mutant protein K762A is not recognized by MAb 13924.
Evidence to support this observation is shown in Fig.
6. Western blot analysis of extracts containing proteins
K746A, K762A, and H782Y shows that while all three
proteins are efficiently detected by the 9CT antipep-
tide serum, MAb 13924 recognizes only K746A (Fig.
6a). Furthermore, the MAb inhibited complex formation
between an OBS I probe and both wt 9CT and K746A,
but DNA binding by K762A was unaffected (Fig. 6b).
Two independent isolates containing the K762A lesion
behaved similarly and DNA sequencing confirmed that
the product of the mutated plasmid was otherwise
identical to wt 9CT. Thus, although K762 lies outside
the region found to be sufficient for MAb 13924 rec-
ognition in the SPOTS assay, this residue nevertheless
appears to contribute to the interaction of the antibody
with the 9CT domain both on a Western blot and in
solution.
FIG. 4. Analysis of DNA binding by mutants altered at lysine residues. (a) Binding at room temperature. Labeled OBS I probe was incubated with
extracts containing the indicated proteins (lanes V and P, incubation with extract from cells transformed with the parental vector and without extract,
respectively) and analyzed as described in the legend to Fig. 1. (b) Binding at 37°C. Same as (a) except that binding reactions and gel electrophoresis
were performed at 37°C. (c) Binding at 4°C. Same as (a) except that binding reactions and gel electrophoresis were performed at 4°C.
FIG. 5. Binding of mutants to an OBS II probe. Labeled OBS II probe
was incubated with extracts containing the indicated proteins (lanes V
and P, incubation with extract from cells transformed with the parental
vector and without extract, respectively) and analyzed as described in
the legend to Fig. 1. Binding and gel electrophoresis were performed at
room temperature.
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DISCUSSION
Comparison of the sequences of the OBPs encoded by
six alphaherpesviruses (HSV-1, VZV, EHV-1, BHV-1, PRV,
and MDV) confirms that the region corresponding ap-
proximately to amino acids 730–810 of HSV-1 UL9 rep-
resents the major conserved sequence block and also
identifies regions corresponding to amino acids 550–
560, 577–624, 687–698, and 828–851 of UL9 that exhibit
significant similarity throughout the subfamily (data not
shown). The major conserved region has previously
been implicated as having a direct role in sequence-
specific recognition since, in Southwestern blots, amino
acids 689–851 of UL9 and the region of HHV-6 OBP
corresponding to UL9 amino acids 712–818 are sufficient
for interaction with their respective recognition se-
quences (Inoue and Pellett, 1995). The results presented
in this paper, and summarized in Fig. 7, provide two
further lines of evidence to support this hypothesis.
First, it was shown that MAb 13924 could block bind-
ing of UL9CT to its recognition sequence and that amino
acids K762 and H782, within the major conserved region,
were important for this interaction. Such an effect could
arise as a consequence of antibody binding in close
physical proximity to a separate DNA-binding site. How-
FIG. 6. MAb 13924 does not react with mutant K762A. (a) Western blots performed on extracts from cells expressing K746A, K762A, and H782Y
proteins. Replicate membranes were probed with MAb 13924 or 9CT antipeptide serum as indicated. (b) Electrophoretic mobility shift assay. Labeled
OBS site I probe was incubated with extracts containing the indicated proteins in the presence or absence of MAb 13924 and analyzed as described
in the legend to Fig. 1. Lanes V, incubation with extract from cells transformed with the parental vector.
FIG. 7. Summary of results. The top part of the figure shows the location of the sequence-specific DNA-binding domain (amino acids 535–851) within
the full-length UL9 protein. The position of mutants K556A, K707A, and K802A are shown. The remaining mutants lie within the hatched area (amino
acids 721–800), the sequence of which is shown in the bottom part. Above the sequence is shown the result of the PredictProtein secondary structure
prediction. Regions scoring maximally (8 or 9) as predicted helices or loops are indicated • and *, respectively. The dots below the sequence indicate
the positions at which the VZV 51 and HSV-1 UL9 proteins are identical. The sequence recognised by MAb 13924 in the SPOTs assay is underlined
and the two residues (K762 and H782) that contribute directly to antibody binding are italicized. The DNA-binding phenotypes of the mutants are
shown as follows: n, essentially as wt 9CT (i.e., binds and produces discrete complexes); }, binds but produces a smeared pattern of complexes;
h, does not bind; m, temperature sensitive for binding.
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ever, since mutations at these or neighboring amino
acids (i.e., K758, K762, and either R783 or Q784) also
appear to have a direct effect on DNA binding it seems
likely that the antibody-binding site corresponds very
closely to the DNA-binding site.
Application of the SPOTs technique identified a linear
peptide comprising amino acids 780–786 that was rec-
ognized by MAb 13924 but the actual epitope is probably
more complex. Within the short peptide, position 782 but
not 783 or 784 contributed to antibody recognition of 9CT
protein, and position 762 was also important both in
solution and Western blots. It seems likely that K762 is
directly recognized by the antibody but the possibility
that its substitution by alanine prevents antibody binding
by an alternative mechanism cannot be excluded. The
observations, nevertheless, suggest that positions 762
and 782 are likely to lie close to one another in the folded
protein.
The second approach involved the examination of the
DNA-binding properties of 10 specific mutants, including
8 substituting alanine for lysine. Of these mutants, only 3
(K707A, H782Y, and K802A) were relatively unaffected in
their DNA-binding ability. The alteration in H782Y corre-
sponds to the single amino acid difference between the
HSV-1 and VZV proteins between amino acids 777 and
786, and since both proteins bind to the same DNA
sequence it is not surprising that this mutant is unaf-
fected. Mutants K707A and K802A contain substitutions
at either end of the major conserved region. Among the
other alphaherpesviruses, substitutions of K707 for R, W,
or V and K802 for D or S occur. Neither of these positions
therefore appears to play a key role in sequence-specific
recognition.
In contrast, the remaining seven mutants were all
affected in their ability to interact with the OBP recogni-
tion sequence. Six of these contain substitutions be-
tween amino acids 733 and 793 within the major con-
served region. The lysine residues at positions 733, 746,
758, 762, and 793 occur in 5, 5, 6, 6, and 3, respectively,
of the six sequenced alphaherpesvirus OBPs. The only
other amino acid occurring at these positions is arginine,
representing a conservative replacement. The retention
of some ability to interact with DNA by mutants K733A,
K746A, K762A, and K793A indicates that these proteins
are not grossly misfolded and suggests that the four
residues all contribute to binding. The double mutant
RQ783AA was phenotypically similar suggesting that
one or both of the altered amino acids may also play a
role. Mutant K758A did not bind detectably to either an
OBS site I or an OBS site II probe at room temperature or
37°C suggesting that this highly conserved lysine resi-
due may have a key role in sequence-specific recogni-
tion, although further analysis is required to exclude the
possibility that the mutant protein is incorrectly folded.
These data extend the information available on mu-
tants with lesions affecting the major conserved region.
Five previously described mutants all contained small
insertions: those altered at positions 744 and 784 did not
exhibit detectable binding while mutations at positions
752, 755, and 799 resulted in significant impairment (Deb
and Deb, 1991; Arbuckle and Stow, 1993; Martin et al.,
1994). The insertions may, however, have more signifi-
cantly affected protein folding than the amino acid sub-
stitutions described in this communication.
Mutant K556A exhibited a temperature-sensitive phe-
notype for sequence-specific DNA binding and thermo-
lability of the polypeptide may have been responsible for
its variable recovery from bacterial cells. Surprisingly,
this mutation lies within a region of the protein (amino
acids 542–564) previously shown to be nonessential for
DNA binding (Deb and Deb, 1991). It is possible that
while being in a nonessential region, the amino acid
substitution may have a long-range effect on the DNA-
binding site. This effect could additionally involve the
nearby N-terminal 12 amino acids of the 9CT protein
which are not present in UL9 itself. Nevertheless, it is
interesting to note that K556 lies in the middle of a small
region of high conservation with the sequence FXXKYL
occurring in all six alphaherpesvirus OBPs at this posi-
tion.
A secondary structure prediction for the C-terminal
DNA-binding domain of the HSV-1 UL9 protein was gen-
erated using the program PredictProtein (EMBL, Heidel-
berg; Rost and Sander, 1993, 1994; Rost et al., 1994). This
program bases its predictions not only on the amino acid
sequence of the test protein but also on alignments with
the sequences of close homologs it identifies in the
databases. In this instance the amino acid sequences of
the EHV-1 and VZV homologs, which are capable of
binding the same DNA sequence, were incorporated.
Of particular interest, within the region containing res-
idues affecting recognition by MAb 13924 and DNA bind-
ing (amino acids 733–793), the sequences 729–738, 765–
768, and 782–794 all scored maximum values for
predicted helices (Fig. 7). It is possible that such helices,
together with the intervening sequences, might fold to
form a ‘‘bundle’’ structure with one of the helices being
primarily responsible for sequence-specific recognition.
Such an arrangement is a common feature of many
sequence-specific DNA-binding proteins (reviewed by
Harrison, 1991). The important lysine residues could po-
tentially participate in interactions with individual bases
or the DNA phosphate chain (reviewed by Luisi, 1995),
and the formation of a helix–loop–helix structure might
account for residues at positions 762 and 782 both influ-
encing recognition by MAb 13924. Ultimately, however, it
is likely that X-ray crystallographic determination of the
structure of the 9CT domain and its complex with its
recognition sequence will be required to test these pre-
dictions.
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